Media Thread, page-6378

Well, a year has passed since I mentioned this:

https://endpts.com/who-are-the-women-blazing-trails-in-biopharma-rd-nominate-them-for-endpoints-2022-special-report/

I just sent in my nomination for Leslie Chong again for this year. It seems that they look for women who have already achieved fame and fortune, " portraits that will both honor and commemorate the contributions these women have made to the creation of new medicines."

But I reminded them that much inspiration can be derived by those still working on new treatments for any disease. We did well submitting nominations for Leslie last year, and although not catching a top rating from Endpoints, we will bring her to the attention of some members of the science media thru nomination.

Therefore I ask all once again to nominate Leslie Chong for this Special Report. Click on the link above.

Thanks all!

NOMINATION

Imugene MD and CEO Leslie Chong

I get the feeling that Endpoints normally goes for the already made news, and doesn't look deep into up and coming therapies.

.......And judging from the response we’ve received, to both our special reports and live events, telling their stories — including any obstacles they may have had to overcome — has inspired our readers in many different ways.......

Inspiration can also be achieved thru great working conditions and good ongoing trial results. This is where you will find the likes of MD and CEO Leslie Chong and staff.

https://www.imugene.com/